In 2021, Pear Therapeutics was worth $1.6B. It sold prescription digital therapeutics with FDA clearance. Two years later, it filed for bankruptcy, and the assets went at auction for $6M. The regulator had let the product through. Then no health plan agreed to pay for it.
